A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CY, Flynn PJ, Mayo Clinic and Mayo Foundation, Rochester, MN - Cancer 2003;97:1442-1446

Author： Trump D.L.  

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.21, Iss.5, 2003-09, pp. : 409-410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients

By Zori Comba A.   Blajman C.   Richardet E.   Bella S.   Vilanova M.   Coppola F.   Van Kooten M.   Rodger J.   Giglio R.   Balbiani L.   Perazzo F.   Montiel M.   Chacon M.   Pujol F.   Mickiewicz E.   Cazap E.   Recondo G.   Lastiri F.   Simon J.   Wasserman E.   Schmilovich A.  

European Journal of Cancer, Vol. 37, Iss. 8, 2001-05 ,pp. : 1006-1013

Elsevier

Access to resources Recommend Favorite

Vinorelbine in androgen-independent metastatic prostatic carcinoma-a phase II study

By Morant R.   Hsu Schmitz S.-F.   Bernhard J.   Thurlimann B.   Borner M.   Wernli M.   Egli F.   Forrer P.   Streit A.   Jacky E.   Hanselmann S.   Bauer J.   Hering F.   Schmid H.-P.   for the Swiss Group for Clinical Cancer Research SAKK  

European Journal of Cancer, Vol. 38, Iss. 12, 2002-08 ,pp. : 1626-1632

Elsevier

Access to resources Recommend Favorite

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Chen B, Zoledronic Acid Prostate Cancer Study Group, Uro-Oncology Clinic, Centre Hospitalier de l'Universite, de Montreal, Hopital Notre-Dame, Montreal, Quebec, Canada - J Natl Cancer Inst 2002;94:1458-1468

By Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 408-408

Elsevier

Access to resources Recommend Favorite

A Phase I/II Study of High-Dose Tamoxifen in Combination with Vinblastine in Patients with Androgen-Independent Prostate Cancer

By Hamilton Michael   Dahut William   Brawley Otis   Davis Patricia   Wells-jones Toni   Kohler David   Duray Paul   Liewehr David J.   Lakhani Nehal   Steinberg Seth M.   Figg William D.   Reed Eddie  

Acta Oncologica, Vol. 42, Iss. 3, 2003-01 ,pp. : 195-201

Informa Healthcare

Access to resources Recommend Favorite

Strontium-89 Combined With Doxorubicin in the Treatment of Patients With Androgen-Independent Prostate Cancer

By Tu S.-M.   Delpassand E.S.   Jones D.   Amato R.J.   Ellerhorst J.   Logothetis C.J.  

Urologic Oncology: Seminars and Original Investigations, Vol. 2, Iss. 6, 1996-11 ,pp. : 191-197

Elsevier

Access to resources Recommend Favorite